TSHR and thyroid cancer: Many studies have reported that BRAFV600E mutation reduces the expression of thyroid iodine-handling genes (sodium iodide symporter, thyroid-stimulating hormone receptor, thyroglobulin, and thyroperoxidase) in thyroid cancer [1, 47, 48].